• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EWS/FLI及其下游靶点NR0B1直接相互作用,以调节尤因肉瘤中的转录和肿瘤发生。

EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.

作者信息

Kinsey Michelle, Smith Richard, Iyer Anita K, McCabe Edward R B, Lessnick Stephen L

机构信息

Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.

出版信息

Cancer Res. 2009 Dec 1;69(23):9047-55. doi: 10.1158/0008-5472.CAN-09-1540. Epub 2009 Nov 17.

DOI:10.1158/0008-5472.CAN-09-1540
PMID:19920188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2789197/
Abstract

Most Ewing's sarcomas harbor chromosomal translocations that encode fusions between EWS and ETS family members. The most common fusion, EWS/FLI, consists of an EWSR1-derived strong transcriptional activation domain fused, in-frame, to the DNA-binding domain-containing portion of FLI1. EWS/FLI functions as an aberrant transcription factor to regulate genes that mediate the oncogenic phenotype of Ewing's sarcoma. One of these regulated genes, NR0B1, encodes a corepressor protein, and likely plays a transcriptional role in tumorigenesis. However, the genes that NR0B1 regulates and the transcription factors it interacts with in Ewing's sarcoma are largely unknown. We used transcriptional profiling and chromatin immunoprecipitation to identify genes that are regulated by NR0B1, and compared these data to similar data for EWS/FLI. Although the transcriptional profile overlapped as expected, we also found that the genome-wide localization of NR0B1 and EWS/FLI overlapped as well, suggesting that they regulate some genes coordinately. Further analysis revealed that NR0B1 and EWS/FLI physically interact. This protein-protein interaction is likely to be relevant for the development of Ewing's sarcoma because mutations in NR0B1 that disrupt the interaction have transcriptional consequences and also abrogate oncogenic transformation. Taken together, these data suggest that EWS/FLI and NR0B1 physically interact, coordinately modulate gene expression, and mediate the transformed phenotype of Ewing's sarcoma.

摘要

大多数尤因肉瘤存在染色体易位,这些易位编码EWS和ETS家族成员之间的融合蛋白。最常见的融合蛋白EWS/FLI由EWSR1衍生的强转录激活结构域与FLI1含DNA结合结构域的部分读框内融合而成。EWS/FLI作为一种异常转录因子发挥作用,调控介导尤因肉瘤致癌表型的基因。其中一个受调控的基因NR0B1编码一种共抑制蛋白,可能在肿瘤发生中发挥转录作用。然而,在尤因肉瘤中NR0B1调控的基因以及与其相互作用的转录因子很大程度上尚不清楚。我们利用转录谱分析和染色质免疫沉淀来鉴定受NR0B1调控的基因,并将这些数据与EWS/FLI的类似数据进行比较。尽管转录谱如预期那样重叠,但我们还发现NR0B1和EWS/FLI在全基因组水平上的定位也重叠,这表明它们协同调控一些基因。进一步分析显示NR0B1和EWS/FLI存在物理相互作用。这种蛋白质-蛋白质相互作用可能与尤因肉瘤的发生发展相关,因为破坏这种相互作用的NR0B1突变具有转录后果,并且还能消除致癌转化。综上所述,这些数据表明EWS/FLI和NR0B1存在物理相互作用,协同调节基因表达,并介导尤因肉瘤的转化表型。

相似文献

1
EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.EWS/FLI及其下游靶点NR0B1直接相互作用,以调节尤因肉瘤中的转录和肿瘤发生。
Cancer Res. 2009 Dec 1;69(23):9047-55. doi: 10.1158/0008-5472.CAN-09-1540. Epub 2009 Nov 17.
2
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.在尤因肉瘤中,EWS/FLI介导的致癌表型需要NR0B1。
Mol Cancer Res. 2006 Nov;4(11):851-9. doi: 10.1158/1541-7786.MCR-06-0090.
3
EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.在尤因肉瘤的致癌转化过程中,EWS/FLI通过NKX2.2介导转录抑制。
PLoS One. 2008 Apr 16;3(4):e1965. doi: 10.1371/journal.pone.0001965.
4
Microsatellites as EWS/FLI response elements in Ewing's sarcoma.微卫星作为尤因肉瘤中EWS/FLI的反应元件
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54. doi: 10.1073/pnas.0801073105. Epub 2008 Jul 14.
5
A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.斑马鱼尤文肉瘤转基因模型揭示了 EWS-FLI1 肿瘤发生的保守介质。
Dis Model Mech. 2012 Jan;5(1):95-106. doi: 10.1242/dmm.007401. Epub 2011 Oct 6.
6
Promiscuous partnerships in Ewing's sarcoma.尤因肉瘤中的混杂伙伴关系。
Cancer Genet. 2011 Jul;204(7):351-65. doi: 10.1016/j.cancergen.2011.07.008.
7
Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.小窝蛋白-1(CAV1)是EWS/FLI-1的一个靶点,也是尤因肉瘤细胞致癌表型和致瘤性的关键决定因素。
Cancer Res. 2006 Oct 15;66(20):9937-47. doi: 10.1158/0008-5472.CAN-06-0927.
8
GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.GSTM4是一种含有微卫星的EWS/FLI靶点,参与尤因肉瘤的肿瘤发生和治疗抗性。
Oncogene. 2009 Nov 19;28(46):4126-32. doi: 10.1038/onc.2009.262. Epub 2009 Aug 31.
9
Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.微卫星是EWS/FLI反应元件:基因组“垃圾”是EWS/FLI的宝藏。
Cell Cycle. 2008 Oct;7(20):3127-32. doi: 10.4161/cc.7.20.6892. Epub 2008 Oct 2.
10
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.EWS/FLI的表达谱分析确定NKX2.2为尤因肉瘤中的关键靶基因。
Cancer Cell. 2006 May;9(5):405-16. doi: 10.1016/j.ccr.2006.04.004.

引用本文的文献

1
Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets.在EWS-FLI驱动的尤因肉瘤中可成药的上调蛋白作为新出现的治疗靶点。
Am J Transl Res. 2025 Mar 15;17(3):1580-1603. doi: 10.62347/YMEU1808. eCollection 2025.
2
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas.用于小儿实体瘤研究的临床前模型:聚焦骨肉瘤
Front Oncol. 2024 Jul 18;14:1388484. doi: 10.3389/fonc.2024.1388484. eCollection 2024.
3
ETS1, a Target Gene of the EWSR1::FLI1 Fusion Oncoprotein, Regulates the Expression of the Focal Adhesion Protein TENSIN3.ETS1 是 EWSR1::FLI1 融合癌蛋白的靶基因,调节黏着斑蛋白 TENSIN3 的表达。
Mol Cancer Res. 2024 Jul 2;22(7):625-641. doi: 10.1158/1541-7786.MCR-23-1090.
4
ETS1, a target gene of the EWSR1::FLI1 fusion oncoprotein, regulates the expression of the focal adhesion protein TENSIN3.ETS1是EWSR1::FLI1融合癌蛋白的一个靶基因,可调节粘着斑蛋白张力蛋白3的表达。
bioRxiv. 2023 Dec 23:2023.12.21.572864. doi: 10.1101/2023.12.21.572864.
5
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.EWS/FLI1 的特征、激活、抑制、靶基因及在尤文肉瘤中的治疗机会。
Int J Mol Sci. 2023 Oct 14;24(20):15173. doi: 10.3390/ijms242015173.
6
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.尤因肉瘤中EWS-FLI1的靶向治疗
Cancers (Basel). 2023 Aug 9;15(16):4035. doi: 10.3390/cancers15164035.
7
Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.筛选 DAX1/EWS-FLI1 功能抑制剂发现二氢乳清酸脱氢酶是尤文肉瘤的治疗靶点。
Cancer Med. 2023 Apr;12(8):9802-9814. doi: 10.1002/cam4.5741. Epub 2023 Feb 24.
8
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.ETS 转录因子 ETV6 限制 EWS-FLI 的转录活性,从而促进尤因肉瘤的发生。
Nat Cell Biol. 2023 Feb;25(2):285-297. doi: 10.1038/s41556-022-01059-8. Epub 2023 Jan 19.
9
The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review.尤因肉瘤中融合蛋白活性的重要性以及调节它的细胞内在和外在因素:综述
Front Oncol. 2022 Nov 24;12:1044707. doi: 10.3389/fonc.2022.1044707. eCollection 2022.
10
AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells.AT 钩 DNA 结合基序包含蛋白 1 敲低下调尤文肉瘤细胞中 EWS-FLI1 的转录活性。
PLoS One. 2022 Oct 4;17(10):e0269077. doi: 10.1371/journal.pone.0269077. eCollection 2022.

本文引用的文献

1
Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells.Dax1与Oct3/4结合并抑制其在胚胎干细胞中的转录活性。
Mol Cell Biol. 2009 Aug;29(16):4574-83. doi: 10.1128/MCB.01863-08. Epub 2009 Jun 15.
2
The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function.致癌性EWS-FLI1蛋白在体内与具有潜在转录激活功能的GGAA微卫星序列结合。
PLoS One. 2009;4(3):e4932. doi: 10.1371/journal.pone.0004932. Epub 2009 Mar 23.
3
Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis.在类固醇生成过程中,Dax-1和类固醇受体RNA激活剂(SRA)作为类固醇生成因子1的转录共激活因子发挥作用。
Mol Cell Biol. 2009 Apr;29(7):1719-34. doi: 10.1128/MCB.01010-08. Epub 2009 Feb 2.
4
Microsatellites as EWS/FLI response elements in Ewing's sarcoma.微卫星作为尤因肉瘤中EWS/FLI的反应元件
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54. doi: 10.1073/pnas.0801073105. Epub 2008 Jul 14.
5
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.DAX1是EWS/FLI1癌蛋白的直接靶点,是尤因氏肿瘤细胞中细胞周期进程的主要调节因子。
Oncogene. 2008 Oct 9;27(46):6034-43. doi: 10.1038/onc.2008.203. Epub 2008 Jun 30.
6
EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.在尤因肉瘤的致癌转化过程中,EWS/FLI通过NKX2.2介导转录抑制。
PLoS One. 2008 Apr 16;3(4):e1965. doi: 10.1371/journal.pone.0001965.
7
An extended transcriptional network for pluripotency of embryonic stem cells.一个关于胚胎干细胞多能性的扩展转录网络。
Cell. 2008 Mar 21;132(6):1049-61. doi: 10.1016/j.cell.2008.02.039.
8
Ewings family oncoproteins: drunk, disorderly and in search of partners.尤因家族癌蛋白:醉态百出、行为紊乱且寻觅搭档。
Cell Res. 2007 Apr;17(4):286-8. doi: 10.1038/cr.2007.22.
9
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.在尤因肉瘤中,EWS/FLI介导的致癌表型需要NR0B1。
Mol Cancer Res. 2006 Nov;4(11):851-9. doi: 10.1158/1541-7786.MCR-06-0090.
10
A protein interaction network for pluripotency of embryonic stem cells.一个用于胚胎干细胞多能性的蛋白质相互作用网络。
Nature. 2006 Nov 16;444(7117):364-8. doi: 10.1038/nature05284. Epub 2006 Nov 8.